abametapir 0.74 % Topical Lotion

RxCUI
2475536
RxNorm name
abametapir 0.74 % Topical Lotion
Display name
abametapir 0.74 % Topical Lotion
Full name
abametapir 0.74 % Topical Lotion
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:58

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
4fe38e95-8738-a28f-4079-43eff7318cb9abametapir 0.74 % Topical LotionPSN4These highlights do not include all the information needed to use XEGLYZE TM safely and effectively. See full prescribing information for XEGLYZE. XEGLYZE (abametapir) lotion, for topical use Initial U.S. Approval: 202020240730
4fe38e95-8738-a28f-4079-43eff7318cb9abametapir 7.4 MG/ML Topical LotionSCD4These highlights do not include all the information needed to use XEGLYZE TM safely and effectively. See full prescribing information for XEGLYZE. XEGLYZE (abametapir) lotion, for topical use Initial U.S. Approval: 202020240730
4fe38e95-8738-a28f-4079-43eff7318cb9abametapir 0.74 % Topical LotionSY4These highlights do not include all the information needed to use XEGLYZE TM safely and effectively. See full prescribing information for XEGLYZE. XEGLYZE (abametapir) lotion, for topical use Initial U.S. Approval: 202020240730